Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr-Reference-Cited by-同舟云学术

Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr

Published:2013-11-25 Issue:5 Volume:15 Page:345-354
ISSN:1399-543X
Container-title:Pediatric Diabetes
language:en
Short-container-title:Pediatr Diabetes

Author:

Max Andersen Marie Louise¹,Nielsen Lotte B¹,Svensson Jannet¹,Pörksen Sven¹,Hougaard Philip²,Beam Craig³,Greenbaum Carla⁴,Becker Dorothy⁵,Petersen Jacob S⁶,Hansen Lars¹,Mortensen Henrik B¹

Affiliation:

1. Department of Pediatrics, Herlev Hospital, Faculty of Health and Medical Sciences; University of Copenhagen; Herlev Denmark

2. Department of Statistics; University of Southern Denmark; Odense Denmark

3. Pediatric Epidemiology Center; University of South Florida; Tampa FL USA

4. Clinical Research Center; Benaroya Research Institute; Seattle WA USA

5. Division of Endocrinology; Children's Hospital of Pittsburgh of UPMC; Pittsburgh PA USA

6. Diabetes Pharmacology and Bioanalysis; Novo Nordisk A/S; Måløv Denmark

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pedi.12098/fullpdf

Reference36 articles.

1. Glucose and C-peptide changes in the perionset period of type 1 diabetes in the diabetes prevention trial − type 1;Sosenko;Diabetes Care,2008

2. Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial − type 1;Sosenko;Diabetes Care,2006

3. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus − a new surrogate measure of non-progression?;Schatz;Pediatr Diabetes,2004

4. The DCCT Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial A randomized, controlled trial;Ann Intern Med,1998

5. Beta-cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial;Steffes;Diabetes Care,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2020-10-09

2. The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno‐metabolic mechanisms;Diabetes/Metabolism Research and Reviews;2019-08-13

3. Prognosis for residual islet β‐cell secretion function in young patients with newly diagnosed type 1 diabetes;Journal of Diabetes;2019-04-22

4. Tapering decay of β‐cell function in Chinese patients with autoimmune type 1 diabetes: A four‐year prospective study;Journal of Diabetes;2019-03-18

5. Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future;International Immunopharmacology;2018-04